PubMed=3740860
Yasuyoshi Miyao, Keiji Shimizu, Yutaka Okamoto, Yutaka Matsui, Yukitaka Ushio, Tatsuo Yoshida, Toru Hayakawa, Nobuyuki Tsuda, Heitaro Mogami;
Meningeal gliomatosis model in nude mice.
Gan To Kagaku Ryoho 13:2600-2605(1986)

PubMed=3496051
Masanobu Yamada, Keiji Shimizu, Yutaka Okamoto, Yasuyoshi Miyao, Yutaka Matsui, Nobuyuki Tsuda, Heitaro Mogami;
Experimental studies on the treatment of recurrent gliomas.
Gan To Kagaku Ryoho 14:1890-1895(1987)

PubMed=2504489
Kazuyoshi Tamura, Keiji Shimizu, Masanobu Yamada, Yutaka Okamoto, Yutaka Matsui, Kae Chang Park, Eiichiro Mabuchi, Shusuke Moriuchi, Heitaro Mogami;
Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation.
Cancer Res. 49:5380-5384(1989)

DOI=10.1016/B978-0-12-333530-2.50005-8
Monica Nister, Bengt Westermark;
Human glioma cell lines.
(In book chapter) Atlas of human tumor cell lines; Hay, Robert J. & Park, Jae-Gahb & Gazdar, Adi F. (eds.); pp.17-42; Academic Press; New York; USA (1994)

PubMed=9310141; DOI=10.1111/j.1349-7006.1997.tb00436.x; PMCID=PMC5921481
Yasuyoshi Miyao, Keiji Shimizu, Masakazu Tamura, Hiromi Akita, Kouji Ikeda, Eiichiro Mabuchi, Haruhiko Kishima, Toru Hayakawa, Kazuhiro Ikenaka;
Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells.
Jpn. J. Cancer Res. 88:678-686(1997)

PubMed=20587068; DOI=10.1186/1471-2407-10-339; PMCID=PMC2909207
Hiromichi Nakabayashi, Toshio Yawata, Keiji Shimizu;
Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells.
BMC Cancer 10:339.1-339.9(2010)